PositoAI/ US/ Geron Corporation

Geron Corporation

NasdaqGS: GERN · Healthcare

Positivity Index

#4,791 / 6,774

Global

#2,490 / 4,000

United States

Positivity Score

18,963

Rank→

Overview Go Deep Penta Pattern Funda News For this company Histo

PosiRed: no active red flags

Geron Corporation — Overview & Financial Snapshot

Geron Corporation (NasdaqGS: GERN) is a Healthcare company, ranked #4,791 of 6,774 companies globally and #2,490 of 4,000 in United States on PositoAI, with a Positivity Score of 18,963. Its market capitalisation is ₹6,852.73 Cr ($725.99M), P/E ratio is -10.3 and P/B ratio is 3.32. It has no active red flags (PosiRed) or yellow flags (PosiYellow) on record.

For financial statements, ratio trends and score history, Go Deep →

Top-ranked Healthcare companies

#3 Dogwood Therapeutics, Inc. 27,827 #8 Impact BioMedical Inc. 26,149 #13 Onconetix, Inc. 25,902 #15 Revelation Biosciences, Inc. 25,780 #18 Vyome Holdings, Inc. 25,696

— Nothing to show —

OpenAI is reading recent news...

Geron Corporation, a commercial-stage biopharmaceutical company, focuses on the development of therapeutics products for oncology. The company's product pipeline includes RYTELO, a telomerase inhibitor for the treatment of adult patients with low- to intermediate-1 risk myelodysplastic syndromes with transfusion-dependent anemia; IMerge which is in Phase 3 clinical trial for the treatment of lower-risk myelodysplastic syndromes; IMpactMF that is in Phase 3 for the treatment of relapsed/refractory myelofibrosis; Impress which is in Phase 2 clinical trial to treat higher risk myelodysplastic syndromes and acute myeloid leukemia (AML); IMproveMF which is in Phase 1 clinical trial for the treatment of frontline myelofibrosis; and IMAGINE which is in phase 1/2 clinical trial for the treatment of relapsed/refractory AML. Geron Corporation was incorporated in 1990 and is headquartered in Foster City, California.

P/B Ratio 3.32

P/E Ratio -10.3

D/E Ratio 0.56

ROE -28.28%

Owes vs Owns ? 0.58× Moderate $0.58 owed for every $1 it owns · balance sheet Jun 2026

Dividend Yield 0.00%

Trailing EPS ₹-10.38$-0.11

Forward EPS ₹3.78$0.04

Beta 0.61

Market Cap ₹6,852.73 Cr$725.99M

What these numbers mean →

What does Geron Corporation do?

What is Geron Corporation's P/E and P/B ratio?

Geron Corporation has a P/E ratio of -10.3 and a P/B ratio of 3.32.

What is Geron Corporation's debt-to-equity ratio?

Geron Corporation has a debt-to-equity ratio of 0.56.

How much does Geron Corporation owe compared with what it owns?

Geron Corporation owes $0.58 for every $1 it owns (balance sheet Jun 2026), which is moderate.

What is Geron Corporation's Positivity rank?

Geron Corporation is ranked #4,791 of 6,774 companies globally and #2,490 of 4,000 in United States on PositoAI, with a Positivity Score of 18,963.

Does Geron Corporation have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?

No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for Geron Corporation.

Where can I read the latest news about Geron Corporation?

Recent headlines about Geron Corporation from the last 30 days, with links to the original articles, are on its News page on PositoAI.

Does Geron Corporation have a PositoAI PosiShot or QR code?

Yes. A dated PosiShot of Geron Corporation's current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.

0 / 1000

🔒 Private — stored only in this browser, never sent to PositoAI. Clear anytime in Settings.